title: Digoxin toxicity: Case for retiring its use in elderly patients?
authors.affiliation: Clinical Information Resource Specialist in the Poison and Drug Information Service at Alberta Health Services in Calgary. nora.macleod-glover@albertahealthservices.ca.
authors.forename: Nora
authors.initials: N
authors.lastname: MacLeod-Glover
authors.affiliation: Educator and Clinical Information Resource Specialist II in the Poison and Drug Information Service.
authors.forename: Matthew
authors.initials: M
authors.lastname: Mink
authors.affiliation: Medical Director in the Poison and Drug Information Service and Clinical Associate Professor in the Department of Emergency Medicine at the University of Calgary.
authors.forename: Mark
authors.initials: M
authors.lastname: Yarema
authors.affiliation: Associate Medical Director of the Poison and Drug Information Service and Clinical Lecturer in the Division of Pharmacology and Toxicology in the Department of Emergency Medicine at the University of Calgary.
authors.forename: Ryan
authors.initials: R
authors.lastname: Chuang
mesh_terms: D000368:Aged; D000889:Anti-Arrhythmia Agents / Q000008:administration & dosage / Q000009:adverse effects*; D004077:Digoxin / Q000008:administration & dosage / Q000009:adverse effects*; D004347:Drug Interactions; D005260:Female; D006801:Humans
chemical_list: D000889:Anti-Arrhythmia Agents; D004077:Digoxin